Bottom-fishing for long-term trading.

KhanhC.Hoang Updated   
NYSE:BAX   Baxter International Inc
According to Wells Fargo Advisors, "BAX: OMCL Would Be An Excellent Fit ... OMCL would bring better IT integration and an expanded set of hospital relationships as Baxter launches a new infusion pump next year. OMCL might also be able to finally realize its vision of a stronger international business (9% of total revenue) with the help of Baxter’s infrastructure. The pandemic pressured OMCL’s original 13% revenue growth target for 2020 down to a 2% revenue decline. However, management indicated bookings surged so much in Q3 the company was able to reinstate its original 9% bookings growth guidance for 2020 and gave a 2021 revenue outlook of 17% growth (13% organic). So, fundamentals seem solid."
Comment: BAX is back to the bottom of its short-term trading range.
Its TipRanks Smart Score is a high neutral. The TipRanks Smart Score is quantitatively derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.